An Efficacy and Safety Study of Palovarotene for the Treatment of MO

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Exostoses, Multiple Hereditary

In brief

This is a randomized, double-blind, placebo-controlled study comparing the safety and efficacy of 2 dosage regimens of palovarotene versus placebo in preventing disease progression in pediatric subjects with multiple osteochondromas (MO).

Key facts

Study ID
NCT03442985
Run by
Clementia Pharmaceuticals Inc.
People needed
193
Starts
2018-03-22
Expected to finish
2020-10-30
Last updated by the study team
2022-08-01

Who can join

Age: 2 and older, up to 14. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.